Compounds specific to adenosine A3 receptor and uses thereof
US6686366B1 · kind B1 · utility
15Cited by
24References
50Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 1999 |
| Grant date | Feb 3, 2004 |
| Priority date | — |
| Expiry date | Dec 2, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention pertains to compounds which specifically inhibit the adenosine A3 receptor and the use of these compounds to treat a disease associated with A3 adenosine receptor in a subject, comprising administering to the subject a therapeutically effective amount of the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.